JP5882058B2 - 組合せ抗体ライブラリー及びその使用 - Google Patents

Info

Publication number

JP5882058B2

JP5882058B2 JP2011535649A JP2011535649A JP5882058B2 JP 5882058 B2 JP5882058 B2 JP 5882058B2 JP 2011535649 A JP2011535649 A JP 2011535649A JP 2011535649 A JP2011535649 A JP 2011535649A JP 5882058 B2 JP5882058 B2 JP 5882058B2

Authority

JP

Japan

Prior art keywords

antibody

germline

chain

human

nucleic acid

Prior art date

2008-11-07

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Fee Related

Links

• Espacenet
• Global Dossier
• Discuss

• 210000004602 germ cell Anatomy 0.000 claims description 561
• 150000007523 nucleic acids Chemical class 0.000 claims description 540
• 102000039446 nucleic acids Human genes 0.000 claims description 408
• 108020004707 nucleic acids Proteins 0.000 claims description 408
• 108090000623 proteins and genes Proteins 0.000 claims description 351
• 238000000034 method Methods 0.000 claims description 268
• 241000282414 Homo sapiens Species 0.000 claims description 192
• 230000027455 binding Effects 0.000 claims description 154
• 238000009739 binding Methods 0.000 claims description 152
• 102000004169 proteins and genes Human genes 0.000 claims description 127
• 150000001413 amino acids Chemical group 0.000 claims description 124
• 239000000427 antigen Substances 0.000 claims description 117
• 102000036639 antigens Human genes 0.000 claims description 117
• 108091007433 antigens Proteins 0.000 claims description 117
• 108020004705 Codon Proteins 0.000 claims description 79
• 230000000694 effects Effects 0.000 claims description 66
• -1 IGHV2- 5 Proteins 0.000 claims description 57
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 56
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 56
• 239000012634 fragment Substances 0.000 claims description 51
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 46
• 239000000203 mixture Substances 0.000 claims description 44
• 108700028369 Alleles Proteins 0.000 claims description 43
• 230000037431 insertion Effects 0.000 claims description 36
• 238000003780 insertion Methods 0.000 claims description 36
• 238000006467 substitution reaction Methods 0.000 claims description 32
• 230000005714 functional activity Effects 0.000 claims description 30
• 238000012216 screening Methods 0.000 claims description 26
• 230000015572 biosynthetic process Effects 0.000 claims description 20
• 101001079285 Homo sapiens Immunoglobulin heavy joining 1 Proteins 0.000 claims description 19
• 102100028078 Immunoglobulin heavy joining 1 Human genes 0.000 claims description 19
• 101000998947 Homo sapiens Immunoglobulin heavy variable 1-46 Proteins 0.000 claims description 18
• 101001091242 Homo sapiens Immunoglobulin kappa joining 1 Proteins 0.000 claims description 18
• 102100036888 Immunoglobulin heavy variable 1-46 Human genes 0.000 claims description 18
• 102100034892 Immunoglobulin kappa joining 1 Human genes 0.000 claims description 18
• 239000000816 peptidomimetic Substances 0.000 claims description 18
• 102000005962 receptors Human genes 0.000 claims description 17
• 108020003175 receptors Proteins 0.000 claims description 17
• 239000007787 solid Substances 0.000 claims description 15
• 241000894007 species Species 0.000 claims description 12
• 101001134437 Homo sapiens Immunoglobulin lambda joining 1 Proteins 0.000 claims description 11
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 11
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 11
• 102100034172 Immunoglobulin lambda joining 1 Human genes 0.000 claims description 11
• 102100023752 Immunoglobulin lambda variable 8-61 Human genes 0.000 claims description 11
• 238000000126 in silico method Methods 0.000 claims description 10
• 239000003446 ligand Substances 0.000 claims description 10
• 101000978126 Homo sapiens Immunoglobulin lambda variable 8-61 Proteins 0.000 claims description 9
• 102100029416 Immunoglobulin heavy variable 6-1 Human genes 0.000 claims description 9
• 102000000844 Cell Surface Receptors Human genes 0.000 claims description 8
• 108010001857 Cell Surface Receptors Proteins 0.000 claims description 8
• 102100036509 Erythropoietin receptor Human genes 0.000 claims description 8
• 101000998950 Homo sapiens Immunoglobulin heavy variable 1-18 Proteins 0.000 claims description 8
• 101001138128 Homo sapiens Immunoglobulin kappa variable 1-12 Proteins 0.000 claims description 8
• 101000604674 Homo sapiens Immunoglobulin kappa variable 4-1 Proteins 0.000 claims description 8
• 102100036884 Immunoglobulin heavy variable 1-18 Human genes 0.000 claims description 8
• 102100020773 Immunoglobulin kappa variable 1-12 Human genes 0.000 claims description 8
• 102100038198 Immunoglobulin kappa variable 4-1 Human genes 0.000 claims description 8
• 102100033553 Delta-like protein 4 Human genes 0.000 claims description 7
• 101000989060 Homo sapiens Immunoglobulin heavy variable 6-1 Proteins 0.000 claims description 7
• 101001047629 Homo sapiens Immunoglobulin kappa variable 2-30 Proteins 0.000 claims description 7
• 102100022952 Immunoglobulin kappa variable 2-30 Human genes 0.000 claims description 7
• 239000012528 membrane Substances 0.000 claims description 7
• 102000001301 EGF receptor Human genes 0.000 claims description 6
• 108060006698 EGF receptor Proteins 0.000 claims description 6
• 101000843762 Homo sapiens Immunoglobulin heavy diversity 1-1 Proteins 0.000 claims description 6
• 101001037142 Homo sapiens Immunoglobulin heavy variable 3-20 Proteins 0.000 claims description 6
• 101001138089 Homo sapiens Immunoglobulin kappa variable 1-39 Proteins 0.000 claims description 6
• 102100030644 Immunoglobulin heavy diversity 1-1 Human genes 0.000 claims description 6
• 102100040218 Immunoglobulin heavy variable 3-20 Human genes 0.000 claims description 6
• 102100029414 Immunoglobulin heavy variable 5-51 Human genes 0.000 claims description 6
• 102100020910 Immunoglobulin kappa variable 1-39 Human genes 0.000 claims description 6
• 101000998953 Homo sapiens Immunoglobulin heavy variable 1-2 Proteins 0.000 claims description 5
• 101000998952 Homo sapiens Immunoglobulin heavy variable 1-3 Proteins 0.000 claims description 5
• 101000998948 Homo sapiens Immunoglobulin heavy variable 1-45 Proteins 0.000 claims description 5
• 101001002931 Homo sapiens Immunoglobulin heavy variable 1-58 Proteins 0.000 claims description 5
• 101001037147 Homo sapiens Immunoglobulin heavy variable 1-69 Proteins 0.000 claims description 5
• 101000998951 Homo sapiens Immunoglobulin heavy variable 1-8 Proteins 0.000 claims description 5
• 101001037138 Homo sapiens Immunoglobulin heavy variable 3-11 Proteins 0.000 claims description 5
• 101000839665 Homo sapiens Immunoglobulin heavy variable 3-43 Proteins 0.000 claims description 5
• 101000839663 Homo sapiens Immunoglobulin heavy variable 3-49 Proteins 0.000 claims description 5
• 101000839660 Homo sapiens Immunoglobulin heavy variable 3-53 Proteins 0.000 claims description 5
• 101000839658 Homo sapiens Immunoglobulin heavy variable 3-66 Proteins 0.000 claims description 5
• 101001037153 Homo sapiens Immunoglobulin heavy variable 3-7 Proteins 0.000 claims description 5
• 101000839659 Homo sapiens Immunoglobulin heavy variable 3-72 Proteins 0.000 claims description 5
• 101000839657 Homo sapiens Immunoglobulin heavy variable 3-73 Proteins 0.000 claims description 5
• 101000839687 Homo sapiens Immunoglobulin heavy variable 3-74 Proteins 0.000 claims description 5
• 101001037144 Homo sapiens Immunoglobulin heavy variable 3-9 Proteins 0.000 claims description 5
• 101000839664 Homo sapiens Probable non-functional immunoglobulin heavy variable 3-38 Proteins 0.000 claims description 5
• 102100036887 Immunoglobulin heavy variable 1-2 Human genes 0.000 claims description 5
• 102100036886 Immunoglobulin heavy variable 1-3 Human genes 0.000 claims description 5
• 102100036889 Immunoglobulin heavy variable 1-45 Human genes 0.000 claims description 5
• 102100020774 Immunoglobulin heavy variable 1-58 Human genes 0.000 claims description 5
• 102100040232 Immunoglobulin heavy variable 1-69 Human genes 0.000 claims description 5
• 102100036885 Immunoglobulin heavy variable 1-8 Human genes 0.000 claims description 5
• 102100040222 Immunoglobulin heavy variable 3-11 Human genes 0.000 claims description 5
• 102100028315 Immunoglobulin heavy variable 3-43 Human genes 0.000 claims description 5
• 102100028319 Immunoglobulin heavy variable 3-49 Human genes 0.000 claims description 5
• 102100028317 Immunoglobulin heavy variable 3-53 Human genes 0.000 claims description 5
• 102100027821 Immunoglobulin heavy variable 3-66 Human genes 0.000 claims description 5
• 102100040231 Immunoglobulin heavy variable 3-7 Human genes 0.000 claims description 5
• 102100027820 Immunoglobulin heavy variable 3-72 Human genes 0.000 claims description 5
• 102100027822 Immunoglobulin heavy variable 3-73 Human genes 0.000 claims description 5
• 102100028305 Immunoglobulin heavy variable 3-74 Human genes 0.000 claims description 5
• 102100040234 Immunoglobulin heavy variable 3-9 Human genes 0.000 claims description 5
• 102100028306 Immunoglobulin heavy variable 4-34 Human genes 0.000 claims description 5
• 102100028312 Immunoglobulin heavy variable 4-39 Human genes 0.000 claims description 5
• 102100028405 Immunoglobulin heavy variable 4-59 Human genes 0.000 claims description 5
• 102100029419 Immunoglobulin heavy variable 4-61 Human genes 0.000 claims description 5
• 206010028980 Neoplasm Diseases 0.000 claims description 5
• 108010070047 Notch Receptors Proteins 0.000 claims description 5
• 102100028318 Probable non-functional immunoglobulin heavy variable 3-38 Human genes 0.000 claims description 5
• 201000011510 cancer Diseases 0.000 claims description 5
• 230000019491 signal transduction Effects 0.000 claims description 5
• 102000000905 Cadherin Human genes 0.000 claims description 4
• 108050007957 Cadherin Proteins 0.000 claims description 4
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 4
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims description 4
• 101500026735 Homo sapiens Brain natriuretic peptide 32 Proteins 0.000 claims description 4
• 101000998949 Homo sapiens Immunoglobulin heavy variable 1-24 Proteins 0.000 claims description 4
• 101001037151 Homo sapiens Immunoglobulin heavy variable 2-70 Proteins 0.000 claims description 4
• 101001037137 Homo sapiens Immunoglobulin heavy variable 3-13 Proteins 0.000 claims description 4
• 101001037136 Homo sapiens Immunoglobulin heavy variable 3-15 Proteins 0.000 claims description 4
• 101001037141 Homo sapiens Immunoglobulin heavy variable 3-21 Proteins 0.000 claims description 4
• 101001037139 Homo sapiens Immunoglobulin heavy variable 3-30 Proteins 0.000 claims description 4
• 101001037143 Homo sapiens Immunoglobulin heavy variable 3-33 Proteins 0.000 claims description 4
• 101000839662 Homo sapiens Immunoglobulin heavy variable 3-48 Proteins 0.000 claims description 4
• 101000839661 Homo sapiens Immunoglobulin heavy variable 3-64 Proteins 0.000 claims description 4
• 101000839683 Homo sapiens Immunoglobulin heavy variable 4-28 Proteins 0.000 claims description 4
• 101000989062 Homo sapiens Immunoglobulin heavy variable 5-51 Proteins 0.000 claims description 4
• 101001138126 Homo sapiens Immunoglobulin kappa variable 1-16 Proteins 0.000 claims description 4
• 101001138125 Homo sapiens Immunoglobulin kappa variable 1-17 Proteins 0.000 claims description 4
• 101001138123 Homo sapiens Immunoglobulin kappa variable 1-27 Proteins 0.000 claims description 4
• 101001138121 Homo sapiens Immunoglobulin kappa variable 1-33 Proteins 0.000 claims description 4
• 101001138133 Homo sapiens Immunoglobulin kappa variable 1-5 Proteins 0.000 claims description 4
• 101001138130 Homo sapiens Immunoglobulin kappa variable 1-9 Proteins 0.000 claims description 4
• 101001008259 Homo sapiens Immunoglobulin kappa variable 1D-12 Proteins 0.000 claims description 4
• 101001008261 Homo sapiens Immunoglobulin kappa variable 1D-13 Proteins 0.000 claims description 4
• 101001008333 Homo sapiens Immunoglobulin kappa variable 1D-16 Proteins 0.000 claims description 4
• 101001008329 Homo sapiens Immunoglobulin kappa variable 1D-33 Proteins 0.000 claims description 4
• 101001008313 Homo sapiens Immunoglobulin kappa variable 1D-39 Proteins 0.000 claims description 4
• 101001008255 Homo sapiens Immunoglobulin kappa variable 1D-8 Proteins 0.000 claims description 4
• 101001047626 Homo sapiens Immunoglobulin kappa variable 2-24 Proteins 0.000 claims description 4
• 101001047627 Homo sapiens Immunoglobulin kappa variable 2-28 Proteins 0.000 claims description 4
• 101001047628 Homo sapiens Immunoglobulin kappa variable 2-29 Proteins 0.000 claims description 4
• 101001047625 Homo sapiens Immunoglobulin kappa variable 2-40 Proteins 0.000 claims description 4
• 101001008321 Homo sapiens Immunoglobulin kappa variable 2D-26 Proteins 0.000 claims description 4
• 101001008293 Homo sapiens Immunoglobulin kappa variable 2D-40 Proteins 0.000 claims description 4
• 101001047618 Homo sapiens Immunoglobulin kappa variable 3-15 Proteins 0.000 claims description 4
• 101001008263 Homo sapiens Immunoglobulin kappa variable 3D-15 Proteins 0.000 claims description 4
• 101001008315 Homo sapiens Immunoglobulin kappa variable 3D-20 Proteins 0.000 claims description 4
• 101000605181 Homo sapiens Immunoglobulin kappa variable 5-2 Proteins 0.000 claims description 4
• 101001090250 Homo sapiens Immunoglobulin kappa variable 6-21 Proteins 0.000 claims description 4
• 101001008317 Homo sapiens Immunoglobulin kappa variable 6D-21 Proteins 0.000 claims description 4
• 101001054844 Homo sapiens Immunoglobulin lambda variable 1-36 Proteins 0.000 claims description 4
• 101001054843 Homo sapiens Immunoglobulin lambda variable 1-40 Proteins 0.000 claims description 4
• 101001054838 Homo sapiens Immunoglobulin lambda variable 1-44 Proteins 0.000 claims description 4
• 101001054837 Homo sapiens Immunoglobulin lambda variable 1-47 Proteins 0.000 claims description 4
• 101001054839 Homo sapiens Immunoglobulin lambda variable 1-51 Proteins 0.000 claims description 4
• 101000578462 Homo sapiens Immunoglobulin lambda variable 10-54 Proteins 0.000 claims description 4
• 101000956884 Homo sapiens Immunoglobulin lambda variable 2-11 Proteins 0.000 claims description 4
• 101000956888 Homo sapiens Immunoglobulin lambda variable 2-18 Proteins 0.000 claims description 4
• 101000956889 Homo sapiens Immunoglobulin lambda variable 2-23 Proteins 0.000 claims description 4
• 101000956887 Homo sapiens Immunoglobulin lambda variable 2-8 Proteins 0.000 claims description 4
• 101001005360 Homo sapiens Immunoglobulin lambda variable 3-1 Proteins 0.000 claims description 4
• 101001005361 Homo sapiens Immunoglobulin lambda variable 3-10 Proteins 0.000 claims description 4
• 101001005363 Homo sapiens Immunoglobulin lambda variable 3-16 Proteins 0.000 claims description 4
• 101001005364 Homo sapiens Immunoglobulin lambda variable 3-19 Proteins 0.000 claims description 4
• 101001005365 Homo sapiens Immunoglobulin lambda variable 3-21 Proteins 0.000 claims description 4
• 101001005336 Homo sapiens Immunoglobulin lambda variable 3-25 Proteins 0.000 claims description 4
• 101001005337 Homo sapiens Immunoglobulin lambda variable 3-27 Proteins 0.000 claims description 4
• 101001005329 Homo sapiens Immunoglobulin lambda variable 3-9 Proteins 0.000 claims description 4
• 101001005330 Homo sapiens Immunoglobulin lambda variable 4-3 Proteins 0.000 claims description 4
• 101001005331 Homo sapiens Immunoglobulin lambda variable 4-60 Proteins 0.000 claims description 4
• 101001005332 Homo sapiens Immunoglobulin lambda variable 4-69 Proteins 0.000 claims description 4
• 101001005333 Homo sapiens Immunoglobulin lambda variable 5-37 Proteins 0.000 claims description 4
• 101001005334 Homo sapiens Immunoglobulin lambda variable 5-39 Proteins 0.000 claims description 4
• 101001005335 Homo sapiens Immunoglobulin lambda variable 5-45 Proteins 0.000 claims description 4
• 101000978130 Homo sapiens Immunoglobulin lambda variable 5-52 Proteins 0.000 claims description 4
• 101000978127 Homo sapiens Immunoglobulin lambda variable 7-46 Proteins 0.000 claims description 4
• 101001037135 Homo sapiens Probable non-functional immunoglobulin heavy variable 3-16 Proteins 0.000 claims description 4
• 101001008319 Homo sapiens Probable non-functional immunoglobulin kappa variable 2D-24 Proteins 0.000 claims description 4
• 101001047520 Homo sapiens Probable non-functional immunoglobulin kappa variable 3-7 Proteins 0.000 claims description 4
• 101001009875 Homo sapiens Probable non-functional immunoglobulin kappa variable 6D-41 Proteins 0.000 claims description 4
• 101000978120 Homo sapiens Probable non-functional immunoglobulin lambda variable 11-55 Proteins 0.000 claims description 4
• 101000956613 Homo sapiens Probable non-functional immunoglobulin lambda variable 2-33 Proteins 0.000 claims description 4
• 101001005338 Homo sapiens Probable non-functional immunoglobulin lambda variable 3-32 Proteins 0.000 claims description 4
• 101001138120 Homo sapiens Probable non-functional immunoglobulinn kappa variable 1-37 Proteins 0.000 claims description 4
• 101001008331 Homo sapiens Probable non-functional immunoglobulinn kappa variable 1D-37 Proteins 0.000 claims description 4
• 102100036890 Immunoglobulin heavy variable 1-24 Human genes 0.000 claims description 4
• 102100040233 Immunoglobulin heavy variable 2-70 Human genes 0.000 claims description 4
• 102100040221 Immunoglobulin heavy variable 3-13 Human genes 0.000 claims description 4
• 102100040224 Immunoglobulin heavy variable 3-15 Human genes 0.000 claims description 4
• 102100040217 Immunoglobulin heavy variable 3-21 Human genes 0.000 claims description 4
• 102100040219 Immunoglobulin heavy variable 3-30 Human genes 0.000 claims description 4
• 102100040236 Immunoglobulin heavy variable 3-33 Human genes 0.000 claims description 4
• 102100028320 Immunoglobulin heavy variable 3-48 Human genes 0.000 claims description 4
• 102100028321 Immunoglobulin heavy variable 3-64 Human genes 0.000 claims description 4
• 102100028311 Immunoglobulin heavy variable 4-28 Human genes 0.000 claims description 4
• 102100028308 Immunoglobulin heavy variable 4-4 Human genes 0.000 claims description 4
• 102100020946 Immunoglobulin kappa variable 1-16 Human genes 0.000 claims description 4
• 102100020945 Immunoglobulin kappa variable 1-17 Human genes 0.000 claims description 4
• 102100020902 Immunoglobulin kappa variable 1-27 Human genes 0.000 claims description 4
• 102100020901 Immunoglobulin kappa variable 1-33 Human genes 0.000 claims description 4
• 102100020769 Immunoglobulin kappa variable 1-5 Human genes 0.000 claims description 4
• 102100020770 Immunoglobulin kappa variable 1-9 Human genes 0.000 claims description 4
• 102100027412 Immunoglobulin kappa variable 1D-12 Human genes 0.000 claims description 4
• 102100027411 Immunoglobulin kappa variable 1D-13 Human genes 0.000 claims description 4
• 102100027462 Immunoglobulin kappa variable 1D-16 Human genes 0.000 claims description 4
• 102100027464 Immunoglobulin kappa variable 1D-33 Human genes 0.000 claims description 4
• 102100027404 Immunoglobulin kappa variable 1D-39 Human genes 0.000 claims description 4
• 102100027406 Immunoglobulin kappa variable 1D-8 Human genes 0.000 claims description 4
• 102100022947 Immunoglobulin kappa variable 2-24 Human genes 0.000 claims description 4
• 102100022950 Immunoglobulin kappa variable 2-28 Human genes 0.000 claims description 4
• 102100022949 Immunoglobulin kappa variable 2-29 Human genes 0.000 claims description 4
• 102100022948 Immunoglobulin kappa variable 2-40 Human genes 0.000 claims description 4
• 102100027460 Immunoglobulin kappa variable 2D-26 Human genes 0.000 claims description 4
• 102100027409 Immunoglobulin kappa variable 2D-40 Human genes 0.000 claims description 4
• 102100022965 Immunoglobulin kappa variable 3-15 Human genes 0.000 claims description 4
• 102100027410 Immunoglobulin kappa variable 3D-15 Human genes 0.000 claims description 4
• 102100027403 Immunoglobulin kappa variable 3D-20 Human genes 0.000 claims description 4
• 102100038241 Immunoglobulin kappa variable 5-2 Human genes 0.000 claims description 4
• 102100034806 Immunoglobulin kappa variable 6-21 Human genes 0.000 claims description 4
• 102100027402 Immunoglobulin kappa variable 6D-21 Human genes 0.000 claims description 4
• 102100026916 Immunoglobulin lambda variable 1-36 Human genes 0.000 claims description 4
• 102100026911 Immunoglobulin lambda variable 1-40 Human genes 0.000 claims description 4
• 102100026921 Immunoglobulin lambda variable 1-44 Human genes 0.000 claims description 4
• 102100026809 Immunoglobulin lambda variable 1-47 Human genes 0.000 claims description 4
• 102100026922 Immunoglobulin lambda variable 1-51 Human genes 0.000 claims description 4
• 102100027972 Immunoglobulin lambda variable 10-54 Human genes 0.000 claims description 4
• 102100038432 Immunoglobulin lambda variable 2-11 Human genes 0.000 claims description 4
• 102100038431 Immunoglobulin lambda variable 2-18 Human genes 0.000 claims description 4
• 102100038430 Immunoglobulin lambda variable 2-23 Human genes 0.000 claims description 4
• 102100038428 Immunoglobulin lambda variable 2-8 Human genes 0.000 claims description 4
• 102100025921 Immunoglobulin lambda variable 3-1 Human genes 0.000 claims description 4
• 102100025919 Immunoglobulin lambda variable 3-10 Human genes 0.000 claims description 4
• 102100025936 Immunoglobulin lambda variable 3-16 Human genes 0.000 claims description 4
• 102100025937 Immunoglobulin lambda variable 3-19 Human genes 0.000 claims description 4
• 102100025934 Immunoglobulin lambda variable 3-21 Human genes 0.000 claims description 4
• 102100025876 Immunoglobulin lambda variable 3-25 Human genes 0.000 claims description 4
• 102100025874 Immunoglobulin lambda variable 3-27 Human genes 0.000 claims description 4
• 102100025864 Immunoglobulin lambda variable 3-9 Human genes 0.000 claims description 4
• 102100025865 Immunoglobulin lambda variable 4-3 Human genes 0.000 claims description 4
• 102100025862 Immunoglobulin lambda variable 4-60 Human genes 0.000 claims description 4
• 102100025863 Immunoglobulin lambda variable 4-69 Human genes 0.000 claims description 4
• 102100025856 Immunoglobulin lambda variable 5-37 Human genes 0.000 claims description 4
• 102100025857 Immunoglobulin lambda variable 5-39 Human genes 0.000 claims description 4
• 102100025855 Immunoglobulin lambda variable 5-45 Human genes 0.000 claims description 4
• 102100023753 Immunoglobulin lambda variable 5-52 Human genes 0.000 claims description 4
• 102100023751 Immunoglobulin lambda variable 7-46 Human genes 0.000 claims description 4
• 108090000542 Lymphotoxin-alpha Proteins 0.000 claims description 4
• 102000004083 Lymphotoxin-alpha Human genes 0.000 claims description 4
• 102100040223 Probable non-functional immunoglobulin heavy variable 3-16 Human genes 0.000 claims description 4
• 102100027461 Probable non-functional immunoglobulin kappa variable 2D-24 Human genes 0.000 claims description 4
• 102100022959 Probable non-functional immunoglobulin kappa variable 3-7 Human genes 0.000 claims description 4
• 102100030885 Probable non-functional immunoglobulin kappa variable 6D-41 Human genes 0.000 claims description 4
• 102100023451 Probable non-functional immunoglobulin lambda variable 11-55 Human genes 0.000 claims description 4
• 102100038489 Probable non-functional immunoglobulin lambda variable 2-33 Human genes 0.000 claims description 4
• 102100025868 Probable non-functional immunoglobulin lambda variable 3-32 Human genes 0.000 claims description 4
• 102100020904 Probable non-functional immunoglobulinn kappa variable 1-37 Human genes 0.000 claims description 4
• 102100027463 Probable non-functional immunoglobulinn kappa variable 1D-37 Human genes 0.000 claims description 4
• 102100040247 Tumor necrosis factor Human genes 0.000 claims description 4
• 230000035755 proliferation Effects 0.000 claims description 4
• 102100032912 CD44 antigen Human genes 0.000 claims description 3
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 3
• 101001037152 Homo sapiens Immunoglobulin heavy variable 2-26 Proteins 0.000 claims description 3
• 101000839682 Homo sapiens Immunoglobulin heavy variable 4-34 Proteins 0.000 claims description 3
• 101000839679 Homo sapiens Immunoglobulin heavy variable 4-39 Proteins 0.000 claims description 3
• 101000839781 Homo sapiens Immunoglobulin heavy variable 4-59 Proteins 0.000 claims description 3
• 101000989076 Homo sapiens Immunoglobulin heavy variable 4-61 Proteins 0.000 claims description 3
• 101001008323 Homo sapiens Immunoglobulin kappa variable 2D-28 Proteins 0.000 claims description 3
• 101001008325 Homo sapiens Immunoglobulin kappa variable 2D-29 Proteins 0.000 claims description 3
• 101001005362 Homo sapiens Immunoglobulin lambda variable 3-12 Proteins 0.000 claims description 3
• 101001037134 Homo sapiens Probable non-functional immunoglobulin heavy variable 3-35 Proteins 0.000 claims description 3
• 101001009876 Homo sapiens Probable non-functional immunoglobulin kappa variable 1D-42 Proteins 0.000 claims description 3
• 101001054840 Homo sapiens Probable non-functional immunoglobulin lambda variable 1-50 Proteins 0.000 claims description 3
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 claims description 3
• 102100040230 Immunoglobulin heavy variable 2-26 Human genes 0.000 claims description 3
• 102100027459 Immunoglobulin kappa variable 2D-28 Human genes 0.000 claims description 3
• 102100027458 Immunoglobulin kappa variable 2D-29 Human genes 0.000 claims description 3
• 102100025920 Immunoglobulin lambda variable 3-12 Human genes 0.000 claims description 3
• 102100040226 Probable non-functional immunoglobulin heavy variable 3-35 Human genes 0.000 claims description 3
• 102100030884 Probable non-functional immunoglobulin kappa variable 1D-42 Human genes 0.000 claims description 3
• 102100026912 Probable non-functional immunoglobulin lambda variable 1-50 Human genes 0.000 claims description 3
• 102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 claims description 3
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 3
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 2
• BJHCYTJNPVGSBZ-YXSASFKJSA-N 1-[4-[6-amino-5-[(Z)-methoxyiminomethyl]pyrimidin-4-yl]oxy-2-chlorophenyl]-3-ethylurea Chemical compound CCNC(=O)Nc1ccc(Oc2ncnc(N)c2\C=N/OC)cc1Cl BJHCYTJNPVGSBZ-YXSASFKJSA-N 0.000 claims description 2
• 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims description 2
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 2
• 102100040843 C-type lectin domain family 4 member M Human genes 0.000 claims description 2
• 102100024217 CAMPATH-1 antigen Human genes 0.000 claims description 2
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims description 2
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims description 2
• 108010065524 CD52 Antigen Proteins 0.000 claims description 2
• 108010021064 CTLA-4 Antigen Proteins 0.000 claims description 2
• 229940045513 CTLA4 antagonist Drugs 0.000 claims description 2
• 102000016289 Cell Adhesion Molecules Human genes 0.000 claims description 2
• 108010067225 Cell Adhesion Molecules Proteins 0.000 claims description 2
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims description 2
• 101710102442 Erythropoietin receptor Proteins 0.000 claims description 2
• 108010011459 Exenatide Proteins 0.000 claims description 2
• 108010008177 Fd immunoglobulins Proteins 0.000 claims description 2
• 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 claims description 2
• 108060003199 Glucagon Proteins 0.000 claims description 2
• 102400000321 Glucagon Human genes 0.000 claims description 2
• DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims description 2
• 102400000326 Glucagon-like peptide 2 Human genes 0.000 claims description 2
• 101800000221 Glucagon-like peptide 2 Proteins 0.000 claims description 2
• 102100039622 Granulocyte colony-stimulating factor receptor Human genes 0.000 claims description 2
• 101710142125 Granulocyte colony-stimulating factor receptor Proteins 0.000 claims description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 2
• 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims description 2
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 2
• 101000749311 Homo sapiens C-type lectin domain family 4 member M Proteins 0.000 claims description 2
• 101000839686 Homo sapiens Immunoglobulin heavy variable 4-4 Proteins 0.000 claims description 2
• 101001138132 Homo sapiens Immunoglobulin kappa variable 1-6 Proteins 0.000 claims description 2
• 101001005366 Homo sapiens Immunoglobulin lambda variable 3-22 Proteins 0.000 claims description 2
• 101000978133 Homo sapiens Immunoglobulin lambda variable 6-57 Proteins 0.000 claims description 2
• 101000978129 Homo sapiens Immunoglobulin lambda variable 9-49 Proteins 0.000 claims description 2
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims description 2
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims description 2
• 101001001487 Homo sapiens Phosphatidylinositol-glycan biosynthesis class F protein Proteins 0.000 claims description 2
• 101000595923 Homo sapiens Placenta growth factor Proteins 0.000 claims description 2
• 101000989063 Homo sapiens Probable non-functional immunoglobulin heavy variable 7-81 Proteins 0.000 claims description 2
• 102100020768 Immunoglobulin kappa variable 1-6 Human genes 0.000 claims description 2
• 102100025935 Immunoglobulin lambda variable 3-22 Human genes 0.000 claims description 2
• 102100023747 Immunoglobulin lambda variable 6-57 Human genes 0.000 claims description 2
• 102100023754 Immunoglobulin lambda variable 9-49 Human genes 0.000 claims description 2
• 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims description 2
• 108010002616 Interleukin-5 Proteins 0.000 claims description 2
• 229940124761 MMP inhibitor Drugs 0.000 claims description 2
• 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims description 2
• 108010004684 Pituitary adenylate cyclase-activating polypeptide Proteins 0.000 claims description 2
• 102100035194 Placenta growth factor Human genes 0.000 claims description 2
• 102100033237 Pro-epidermal growth factor Human genes 0.000 claims description 2
• 102100040918 Pro-glucagon Human genes 0.000 claims description 2
• 102100029413 Probable non-functional immunoglobulin heavy variable 7-81 Human genes 0.000 claims description 2
• 102000001253 Protein Kinase Human genes 0.000 claims description 2
• 108091005682 Receptor kinases Proteins 0.000 claims description 2
• 101710113649 Thyroid peroxidase Proteins 0.000 claims description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 2
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims description 2
• 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 claims description 2
• 101710187743 Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 claims description 2
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims description 2
• 108010073923 Vascular Endothelial Growth Factor C Proteins 0.000 claims description 2
• 108010073919 Vascular Endothelial Growth Factor D Proteins 0.000 claims description 2
• 108010053096 Vascular Endothelial Growth Factor Receptor-1 Proteins 0.000 claims description 2
• 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 claims description 2
• 102100038232 Vascular endothelial growth factor C Human genes 0.000 claims description 2
• 102100038234 Vascular endothelial growth factor D Human genes 0.000 claims description 2
• 102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 claims description 2
• 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims description 2
• 230000006907 apoptotic process Effects 0.000 claims description 2
• 230000004709 cell invasion Effects 0.000 claims description 2
• 230000004663 cell proliferation Effects 0.000 claims description 2
• JUFFVKRROAPVBI-PVOYSMBESA-N chembl1210015 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@H]1[C@@H]([C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@]3(O[C@@H](C[C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C3)C(O)=O)O2)O)[C@@H](CO)O1)NC(C)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 JUFFVKRROAPVBI-PVOYSMBESA-N 0.000 claims description 2
• 230000035605 chemotaxis Effects 0.000 claims description 2
• 102000003675 cytokine receptors Human genes 0.000 claims description 2
• 108010057085 cytokine receptors Proteins 0.000 claims description 2
• 230000003511 endothelial effect Effects 0.000 claims description 2
• 229960001519 exenatide Drugs 0.000 claims description 2
• MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims description 2
• 229960004666 glucagon Drugs 0.000 claims description 2
• TWSALRJGPBVBQU-PKQQPRCHSA-N glucagon-like peptide 2 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O)[C@@H](C)CC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=CC=C1 TWSALRJGPBVBQU-PKQQPRCHSA-N 0.000 claims description 2
• 108010044426 integrins Proteins 0.000 claims description 2
• 102000006495 integrins Human genes 0.000 claims description 2
• 230000008611 intercellular interaction Effects 0.000 claims description 2
• 108010082117 matrigel Proteins 0.000 claims description 2
• 108010092408 Eosinophil Peroxidase Proteins 0.000 claims 2
• 101150029707 ERBB2 gene Proteins 0.000 claims 1
• 102100028471 Eosinophil peroxidase Human genes 0.000 claims 1
• 102100021866 Hepatocyte growth factor Human genes 0.000 claims 1
• 101000872077 Homo sapiens Delta-like protein 4 Proteins 0.000 claims 1
• 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 claims 1
• 101001037140 Homo sapiens Immunoglobulin heavy variable 3-23 Proteins 0.000 claims 1
• 101001047617 Homo sapiens Immunoglobulin kappa variable 3-11 Proteins 0.000 claims 1
• 101001047619 Homo sapiens Immunoglobulin kappa variable 3-20 Proteins 0.000 claims 1
• 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 claims 1
• 101000868152 Homo sapiens Son of sevenless homolog 1 Proteins 0.000 claims 1
• 102000009786 Immunoglobulin Constant Regions Human genes 0.000 claims 1
• 108010009817 Immunoglobulin Constant Regions Proteins 0.000 claims 1
• 102100040220 Immunoglobulin heavy variable 3-23 Human genes 0.000 claims 1
• 102100022955 Immunoglobulin kappa variable 3-11 Human genes 0.000 claims 1
• 102100022964 Immunoglobulin kappa variable 3-20 Human genes 0.000 claims 1
• 102000014736 Notch Human genes 0.000 claims 1
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims 1
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims 1
• 102400000979 Pituitary adenylate cyclase-activating polypeptide 38 Human genes 0.000 claims 1
• 101710098940 Pro-epidermal growth factor Proteins 0.000 claims 1
• 101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 claims 1
• 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 claims 1
• 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 claims 1
• 108010073925 Vascular Endothelial Growth Factor B Proteins 0.000 claims 1
• 108010053100 Vascular Endothelial Growth Factor Receptor-3 Proteins 0.000 claims 1
• 102100038217 Vascular endothelial growth factor B Human genes 0.000 claims 1
• 102100033179 Vascular endothelial growth factor receptor 3 Human genes 0.000 claims 1
• UFTCZKMBJOPXDM-XXFCQBPRSA-N pituitary adenylate cyclase-activating polypeptide Chemical compound C([C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CN=CN1 UFTCZKMBJOPXDM-XXFCQBPRSA-N 0.000 claims 1
• 230000002194 synthesizing effect Effects 0.000 claims 1
• 125000003729 nucleotide group Chemical group 0.000 description 250
• 239000002773 nucleotide Substances 0.000 description 245
• 108090000765 processed proteins & peptides Proteins 0.000 description 156
• 235000001014 amino acid Nutrition 0.000 description 121
• 229940024606 amino acid Drugs 0.000 description 115
• 102000004196 processed proteins & peptides Human genes 0.000 description 111
• 108091028043 Nucleic acid sequence Proteins 0.000 description 107
• 229920001184 polypeptide Polymers 0.000 description 88
• 239000013598 vector Substances 0.000 description 85
• 210000004027 cell Anatomy 0.000 description 67
• 235000018102 proteins Nutrition 0.000 description 61
• 230000014509 gene expression Effects 0.000 description 59
• 102000053602 DNA Human genes 0.000 description 47
• 108020004414 DNA Proteins 0.000 description 46
• 125000003275 alpha amino acid group Chemical group 0.000 description 43
• 238000005215 recombination Methods 0.000 description 36
• 230000006798 recombination Effects 0.000 description 35
• 108091034117 Oligonucleotide Proteins 0.000 description 34
• 125000005647 linker group Chemical group 0.000 description 31
• 108091008146 restriction endonucleases Proteins 0.000 description 29
• 238000012217 deletion Methods 0.000 description 27
• 230000037430 deletion Effects 0.000 description 27
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 27
• 230000006870 function Effects 0.000 description 26
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 25
• 230000008569 process Effects 0.000 description 25
• 102000040430 polynucleotide Human genes 0.000 description 24
• 108091033319 polynucleotide Proteins 0.000 description 24
• 239000002157 polynucleotide Substances 0.000 description 24
• 238000004422 calculation algorithm Methods 0.000 description 23
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 22
• 229910052739 hydrogen Inorganic materials 0.000 description 22
• 229920002477 rna polymer Polymers 0.000 description 22
• 238000003786 synthesis reaction Methods 0.000 description 22
• 230000008859 change Effects 0.000 description 20
• 230000035772 mutation Effects 0.000 description 19
• 238000000746 purification Methods 0.000 description 19
• 108060003951 Immunoglobulin Proteins 0.000 description 18
• 102000018358 immunoglobulin Human genes 0.000 description 18
• 239000013612 plasmid Substances 0.000 description 18
• 238000003752 polymerase chain reaction Methods 0.000 description 16
• 238000011282 treatment Methods 0.000 description 16
• 201000010099 disease Diseases 0.000 description 15
• 238000004519 manufacturing process Methods 0.000 description 15
• 230000004048 modification Effects 0.000 description 15
• 238000012986 modification Methods 0.000 description 15
• 239000013615 primer Substances 0.000 description 15
• 102100028310 Immunoglobulin heavy variable 4-31 Human genes 0.000 description 14
• 125000000539 amino acid group Chemical group 0.000 description 14
• 230000001850 reproductive effect Effects 0.000 description 14
• 108700010070 Codon Usage Proteins 0.000 description 13
• 230000006820 DNA synthesis Effects 0.000 description 13
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 13
• 101000839684 Homo sapiens Immunoglobulin heavy variable 4-31 Proteins 0.000 description 12
• 239000000523 sample Substances 0.000 description 12
• 102000035195 Peptidases Human genes 0.000 description 11
• 108091005804 Peptidases Proteins 0.000 description 11
• 108091093037 Peptide nucleic acid Proteins 0.000 description 11
• 238000007792 addition Methods 0.000 description 11
• 238000005304 joining Methods 0.000 description 11
• 239000000126 substance Substances 0.000 description 11
• 238000012360 testing method Methods 0.000 description 11
• 230000001225 therapeutic effect Effects 0.000 description 11
• 238000010367 cloning Methods 0.000 description 10
• 150000001875 compounds Chemical class 0.000 description 10
• 208000035475 disorder Diseases 0.000 description 10
• 239000013604 expression vector Substances 0.000 description 10
• 238000002864 sequence alignment Methods 0.000 description 10
• 208000024891 symptom Diseases 0.000 description 10
• NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 9
• 101150097493 D gene Proteins 0.000 description 9
• 108020004511 Recombinant DNA Proteins 0.000 description 9
• 238000003491 array Methods 0.000 description 9
• 230000000295 complement effect Effects 0.000 description 9
• 239000011159 matrix material Substances 0.000 description 9
• 239000002245 particle Substances 0.000 description 9
• 108090000394 Erythropoietin Proteins 0.000 description 8
• 101150117115 V gene Proteins 0.000 description 8
• 230000004075 alteration Effects 0.000 description 8
• 238000013459 approach Methods 0.000 description 8
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 8
• 238000005516 engineering process Methods 0.000 description 8
• 238000009396 hybridization Methods 0.000 description 8
• 230000003993 interaction Effects 0.000 description 8
• 230000001788 irregular Effects 0.000 description 8
• 108091035707 Consensus sequence Proteins 0.000 description 7
• 102000003951 Erythropoietin Human genes 0.000 description 7
• 101150008942 J gene Proteins 0.000 description 7
• 241001465754 Metazoa Species 0.000 description 7
• 239000000556 agonist Substances 0.000 description 7
• 238000004458 analytical method Methods 0.000 description 7
• 210000003719 b-lymphocyte Anatomy 0.000 description 7
• 230000002068 genetic effect Effects 0.000 description 7
• 239000000463 material Substances 0.000 description 7
• 238000001823 molecular biology technique Methods 0.000 description 7
• 239000011347 resin Substances 0.000 description 7
• 229920005989 resin Polymers 0.000 description 7
• 101710112728 Delta-like protein 4 Proteins 0.000 description 6
• 108010075944 Erythropoietin Receptors Proteins 0.000 description 6
• 241000700605 Viruses Species 0.000 description 6
• 230000004913 activation Effects 0.000 description 6
• 238000001994 activation Methods 0.000 description 6
• 230000001580 bacterial effect Effects 0.000 description 6
• 239000011324 bead Substances 0.000 description 6
• 230000001413 cellular effect Effects 0.000 description 6
• 238000001514 detection method Methods 0.000 description 6
• 239000003814 drug Substances 0.000 description 6
• 239000012636 effector Substances 0.000 description 6
• 229940105423 erythropoietin Drugs 0.000 description 6
• 238000011156 evaluation Methods 0.000 description 6
• 230000001976 improved effect Effects 0.000 description 6
• 239000002609 medium Substances 0.000 description 6
• 238000002703 mutagenesis Methods 0.000 description 6
• 231100000350 mutagenesis Toxicity 0.000 description 6
• 230000008520 organization Effects 0.000 description 6
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 6
• 230000002265 prevention Effects 0.000 description 6
• 239000000047 product Substances 0.000 description 6
• 238000003860 storage Methods 0.000 description 6
• 229910052720 vanadium Inorganic materials 0.000 description 6
• 102000004190 Enzymes Human genes 0.000 description 5
• 108090000790 Enzymes Proteins 0.000 description 5
• 241000588724 Escherichia coli Species 0.000 description 5
• 239000004471 Glycine Substances 0.000 description 5
• 241000282412 Homo Species 0.000 description 5
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 5
• 238000004590 computer program Methods 0.000 description 5
• 238000010586 diagram Methods 0.000 description 5
• 229940088598 enzyme Drugs 0.000 description 5
• 238000001976 enzyme digestion Methods 0.000 description 5
• 238000000338 in vitro Methods 0.000 description 5
• 238000001727 in vivo Methods 0.000 description 5
• 238000010348 incorporation Methods 0.000 description 5
• 230000001965 increasing effect Effects 0.000 description 5
• 150000008300 phosphoramidites Chemical class 0.000 description 5
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 5
• 125000006239 protecting group Chemical group 0.000 description 5
• 210000001519 tissue Anatomy 0.000 description 5
• 230000014616 translation Effects 0.000 description 5
• 102000005650 Notch Receptors Human genes 0.000 description 4
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical group O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
• 238000000137 annealing Methods 0.000 description 4
• 239000005557 antagonist Substances 0.000 description 4
• 230000008901 benefit Effects 0.000 description 4
• 230000004071 biological effect Effects 0.000 description 4
• 229920001222 biopolymer Polymers 0.000 description 4
• 239000012707 chemical precursor Substances 0.000 description 4
• 238000006243 chemical reaction Methods 0.000 description 4
• 239000003795 chemical substances by application Substances 0.000 description 4
• 239000005547 deoxyribonucleotide Substances 0.000 description 4
• 210000003527 eukaryotic cell Anatomy 0.000 description 4
• 239000012530 fluid Substances 0.000 description 4
• 238000001390 forced Rayleigh scattering spectroscopy Methods 0.000 description 4
• 238000009472 formulation Methods 0.000 description 4
• 229940072221 immunoglobulins Drugs 0.000 description 4
• 238000007726 management method Methods 0.000 description 4
• 239000000178 monomer Substances 0.000 description 4
• 238000005457 optimization Methods 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
• 210000001236 prokaryotic cell Anatomy 0.000 description 4
• 238000011160 research Methods 0.000 description 4
• 238000002741 site-directed mutagenesis Methods 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• 229940124597 therapeutic agent Drugs 0.000 description 4
• 238000004809 thin layer chromatography Methods 0.000 description 4
• 241000894006 Bacteria Species 0.000 description 3
• 241000196324 Embryophyta Species 0.000 description 3
• 101001138131 Homo sapiens Immunoglobulin kappa variable 1-8 Proteins 0.000 description 3
• 101001009877 Homo sapiens Immunoglobulin kappa variable 1D-43 Proteins 0.000 description 3
• 101001008257 Homo sapiens Immunoglobulin kappa variable 3D-11 Proteins 0.000 description 3
• 101000956885 Homo sapiens Immunoglobulin lambda variable 2-14 Proteins 0.000 description 3
• 101000978132 Homo sapiens Immunoglobulin lambda variable 7-43 Proteins 0.000 description 3
• 102000003839 Human Proteins Human genes 0.000 description 3
• 108090000144 Human Proteins Proteins 0.000 description 3
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 3
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 3
• 102100020771 Immunoglobulin kappa variable 1-8 Human genes 0.000 description 3
• 102100030883 Immunoglobulin kappa variable 1D-43 Human genes 0.000 description 3
• 102100027405 Immunoglobulin kappa variable 3D-11 Human genes 0.000 description 3
• 102100038429 Immunoglobulin lambda variable 2-14 Human genes 0.000 description 3
• 102100023746 Immunoglobulin lambda variable 7-43 Human genes 0.000 description 3
• 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 3
• 101710184277 Insulin-like growth factor 1 receptor Proteins 0.000 description 3
• 150000008575 L-amino acids Chemical class 0.000 description 3
• 239000004365 Protease Substances 0.000 description 3
• 108091081024 Start codon Proteins 0.000 description 3
• 108700005078 Synthetic Genes Proteins 0.000 description 3
• 230000000890 antigenic effect Effects 0.000 description 3
• 239000012472 biological sample Substances 0.000 description 3
• 210000000349 chromosome Anatomy 0.000 description 3
• 230000004186 co-expression Effects 0.000 description 3
• 230000021615 conjugation Effects 0.000 description 3
• 238000007796 conventional method Methods 0.000 description 3
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 3
• 238000013461 design Methods 0.000 description 3
• 230000004069 differentiation Effects 0.000 description 3
• 230000029087 digestion Effects 0.000 description 3
• 230000002255 enzymatic effect Effects 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 239000001963 growth medium Substances 0.000 description 3
• 230000028993 immune response Effects 0.000 description 3
• 230000002998 immunogenetic effect Effects 0.000 description 3
• 230000006698 induction Effects 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 229920002521 macromolecule Polymers 0.000 description 3
• 238000013507 mapping Methods 0.000 description 3
• 230000007246 mechanism Effects 0.000 description 3
• 230000003278 mimic effect Effects 0.000 description 3
• 239000006072 paste Substances 0.000 description 3
• 210000002381 plasma Anatomy 0.000 description 3
• 239000002987 primer (paints) Substances 0.000 description 3
• 238000012545 processing Methods 0.000 description 3
• 230000001105 regulatory effect Effects 0.000 description 3
• 230000002441 reversible effect Effects 0.000 description 3
• 230000011664 signaling Effects 0.000 description 3
• 230000006641 stabilisation Effects 0.000 description 3
• 238000011105 stabilization Methods 0.000 description 3
• 235000000346 sugar Nutrition 0.000 description 3
• 230000001629 suppression Effects 0.000 description 3
• 238000001308 synthesis method Methods 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 230000035897 transcription Effects 0.000 description 3
• 238000013518 transcription Methods 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• 238000013519 translation Methods 0.000 description 3
• 230000003612 virological effect Effects 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• OJHZNMVJJKMFGX-RNWHKREASA-N (4r,4ar,7ar,12bs)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;2,3-dihydroxybutanedioic acid Chemical compound OC(=O)C(O)C(O)C(O)=O.O=C([C@@H]1O2)CC[C@H]3[C@]4([H])N(C)CC[C@]13C1=C2C(OC)=CC=C1C4 OJHZNMVJJKMFGX-RNWHKREASA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 241000283707 Capra Species 0.000 description 2
• 108091026890 Coding region Proteins 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 2
• 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 2
• 238000012270 DNA recombination Methods 0.000 description 2
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
• 102100031780 Endonuclease Human genes 0.000 description 2
• 241000233866 Fungi Species 0.000 description 2
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
• 241000238631 Hexapoda Species 0.000 description 2
• 101001037145 Homo sapiens Immunoglobulin heavy variable 2-5 Proteins 0.000 description 2
• 101001008253 Homo sapiens Immunoglobulin kappa variable 3D-7 Proteins 0.000 description 2
• 101001005499 Homo sapiens Probable non-functional immunoglobulin lambda variable 5-48 Proteins 0.000 description 2
• 101000911753 Homo sapiens Protein FAM107B Proteins 0.000 description 2
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
• 101150024642 IGHV4-31 gene Proteins 0.000 description 2
• 101150062520 IGHV4-34 gene Proteins 0.000 description 2
• 101150047109 IGHV4-39 gene Proteins 0.000 description 2
• 101150049792 IGHV4-4 gene Proteins 0.000 description 2
• 101150071874 IGHV4-59 gene Proteins 0.000 description 2
• 101150068285 IGHV4-61 gene Proteins 0.000 description 2
• 101150101036 IGHV5-51 gene Proteins 0.000 description 2
• 101150024404 IGHV6-1 gene Proteins 0.000 description 2
• 101150025860 IGHV7-81 gene Proteins 0.000 description 2
• 101150037605 IGLV8-61 gene Proteins 0.000 description 2
• 101150035487 IGLV9-49 gene Proteins 0.000 description 2
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 2
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 2
• 102100040235 Immunoglobulin heavy variable 2-5 Human genes 0.000 description 2
• 102100027407 Immunoglobulin kappa variable 3D-7 Human genes 0.000 description 2
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
• 241000699666 Mus <mouse, genus> Species 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• 108091005461 Nucleic proteins Proteins 0.000 description 2
• 239000004677 Nylon Substances 0.000 description 2
• 102000016979 Other receptors Human genes 0.000 description 2
• 238000012408 PCR amplification Methods 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• 102100025167 Probable non-functional immunoglobulin lambda variable 5-48 Human genes 0.000 description 2
• 102100026983 Protein FAM107B Human genes 0.000 description 2
• 108020005067 RNA Splice Sites Proteins 0.000 description 2
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
• 108091028664 Ribonucleotide Proteins 0.000 description 2
• XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
• 108020005038 Terminator Codon Proteins 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 230000007720 allelic exclusion Effects 0.000 description 2
• 125000003277 amino group Chemical group 0.000 description 2
• 230000003321 amplification Effects 0.000 description 2
• 229940124691 antibody therapeutics Drugs 0.000 description 2
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 210000001124 body fluid Anatomy 0.000 description 2
• 239000010839 body fluid Substances 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 210000000234 capsid Anatomy 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 238000004440 column chromatography Methods 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 239000006071 cream Substances 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 238000013500 data storage Methods 0.000 description 2
• 239000000539 dimer Substances 0.000 description 2
• 208000037765 diseases and disorders Diseases 0.000 description 2
• 238000010494 dissociation reaction Methods 0.000 description 2
• 230000005593 dissociations Effects 0.000 description 2
• 229940079593 drug Drugs 0.000 description 2
• 206010014599 encephalitis Diseases 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 238000001502 gel electrophoresis Methods 0.000 description 2
• 239000011521 glass Substances 0.000 description 2
• 235000013882 gravy Nutrition 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 229940022353 herceptin Drugs 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• 230000001900 immune effect Effects 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 239000000411 inducer Substances 0.000 description 2
• 239000012678 infectious agent Substances 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 230000010354 integration Effects 0.000 description 2
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 239000006210 lotion Substances 0.000 description 2
• 239000012139 lysis buffer Substances 0.000 description 2
• 108020004999 messenger RNA Proteins 0.000 description 2
• 238000006386 neutralization reaction Methods 0.000 description 2
• 238000003199 nucleic acid amplification method Methods 0.000 description 2
• 239000002777 nucleoside Substances 0.000 description 2
• 229920001778 nylon Polymers 0.000 description 2
• 150000002894 organic compounds Chemical class 0.000 description 2
• 238000004806 packaging method and process Methods 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 244000052769 pathogen Species 0.000 description 2
• 230000008506 pathogenesis Effects 0.000 description 2
• 238000002823 phage display Methods 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 238000001742 protein purification Methods 0.000 description 2
• 238000001243 protein synthesis Methods 0.000 description 2
• 230000002285 radioactive effect Effects 0.000 description 2
• 238000002708 random mutagenesis Methods 0.000 description 2
• 230000008707 rearrangement Effects 0.000 description 2
• 239000002336 ribonucleotide Substances 0.000 description 2
• 125000002652 ribonucleotide group Chemical group 0.000 description 2
• 229960004641 rituximab Drugs 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 230000007781 signaling event Effects 0.000 description 2
• 239000007790 solid phase Substances 0.000 description 2
• 150000008163 sugars Chemical class 0.000 description 2
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
• 239000003053 toxin Substances 0.000 description 2
• 231100000765 toxin Toxicity 0.000 description 2
• 108700012359 toxins Proteins 0.000 description 2
• 230000005945 translocation Effects 0.000 description 2
• 230000017105 transposition Effects 0.000 description 2
• 239000013638 trimer Substances 0.000 description 2
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 2
• 229940045145 uridine Drugs 0.000 description 2
• 239000013603 viral vector Substances 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
• YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
• 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• CKTSBUTUHBMZGZ-ULQXZJNLSA-N 4-amino-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-tritiopyrimidin-2-one Chemical compound O=C1N=C(N)C([3H])=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-ULQXZJNLSA-N 0.000 description 1
• 229930024421 Adenine Natural products 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 108010032595 Antibody Binding Sites Proteins 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 101710158075 Bucky ball Proteins 0.000 description 1
• 101150111062 C gene Proteins 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 description 1
• 102100024153 Cadherin-15 Human genes 0.000 description 1
• 101100366043 Caenorhabditis elegans sms-2 gene Proteins 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 241000282994 Cervidae Species 0.000 description 1
• 229920002101 Chitin Polymers 0.000 description 1
• 108020004638 Circular DNA Proteins 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
• 241000195493 Cryptophyta Species 0.000 description 1
• UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• 230000004568 DNA-binding Effects 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 206010061818 Disease progression Diseases 0.000 description 1
• 101800003838 Epidermal growth factor Proteins 0.000 description 1
• 241001646716 Escherichia coli K-12 Species 0.000 description 1
• KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
• 241000372837 Fumana Species 0.000 description 1
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 1
• 241000282575 Gorilla Species 0.000 description 1
• 102100031547 HLA class II histocompatibility antigen, DO alpha chain Human genes 0.000 description 1
• 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 1
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 1
• 101000762242 Homo sapiens Cadherin-15 Proteins 0.000 description 1
• 101000714553 Homo sapiens Cadherin-3 Proteins 0.000 description 1
• 101000866278 Homo sapiens HLA class II histocompatibility antigen, DO alpha chain Proteins 0.000 description 1
• 101100018617 Homo sapiens IGLL1 gene Proteins 0.000 description 1
• 101000989058 Homo sapiens Immunoglobulin heavy variable 1-69-2 Proteins 0.000 description 1
• 101000989065 Homo sapiens Immunoglobulin heavy variable 7-4-1 Proteins 0.000 description 1
• 101000839685 Homo sapiens Probable non-functional immunoglobulin heavy variable 1-38-4 Proteins 0.000 description 1
• 101000693970 Homo sapiens Scavenger receptor class A member 3 Proteins 0.000 description 1
• 101150050798 IGKV1-39 gene Proteins 0.000 description 1
• 102000013463 Immunoglobulin Light Chains Human genes 0.000 description 1
• 108010065825 Immunoglobulin Light Chains Proteins 0.000 description 1
• 102100029422 Immunoglobulin heavy variable 1-69-2 Human genes 0.000 description 1
• 102100029420 Immunoglobulin heavy variable 7-4-1 Human genes 0.000 description 1
• 102100029616 Immunoglobulin lambda-like polypeptide 1 Human genes 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000000743 Interleukin-5 Human genes 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 102000004310 Ion Channels Human genes 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 102000003960 Ligases Human genes 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 108700005084 Multigene Family Proteins 0.000 description 1
• 108010021466 Mutant Proteins Proteins 0.000 description 1
• 102000008300 Mutant Proteins Human genes 0.000 description 1
• 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 108091092724 Noncoding DNA Proteins 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 102000002808 Pituitary adenylate cyclase-activating polypeptide Human genes 0.000 description 1
• 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
• 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
• 239000004743 Polypropylene Substances 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 102100028309 Probable non-functional immunoglobulin heavy variable 1-38-4 Human genes 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 230000004570 RNA-binding Effects 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 241000282849 Ruminantia Species 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 101710172711 Structural protein Proteins 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 241000282898 Sus scrofa Species 0.000 description 1
• 102100027188 Thyroid peroxidase Human genes 0.000 description 1
• 101710120037 Toxin CcdB Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 229910052770 Uranium Inorganic materials 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 108020005202 Viral DNA Proteins 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 208000009956 adenocarcinoma Diseases 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 238000005273 aeration Methods 0.000 description 1
• 230000009824 affinity maturation Effects 0.000 description 1
• 150000001371 alpha-amino acids Chemical class 0.000 description 1
• 235000008206 alpha-amino acids Nutrition 0.000 description 1
• 230000001668 ameliorated effect Effects 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 230000009830 antibody antigen interaction Effects 0.000 description 1
• 229940125644 antibody drug Drugs 0.000 description 1
• 229940125752 antibody drug candidate Drugs 0.000 description 1
• 238000011091 antibody purification Methods 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 210000004507 artificial chromosome Anatomy 0.000 description 1
• 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 238000012550 audit Methods 0.000 description 1
• 229940120638 avastin Drugs 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 229960000397 bevacizumab Drugs 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 239000012620 biological material Substances 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 238000005422 blasting Methods 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 125000002843 carboxylic acid group Chemical group 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 239000003054 catalyst Substances 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 238000001193 catalytic steam reforming Methods 0.000 description 1
• 238000000423 cell based assay Methods 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000011712 cell development Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
• 238000004182 chemical digestion Methods 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 210000003763 chloroplast Anatomy 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 238000007621 cluster analysis Methods 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 239000002131 composite material Substances 0.000 description 1
• 239000000039 congener Substances 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 238000012937 correction Methods 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
• UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 239000000412 dendrimer Substances 0.000 description 1
• 229920000736 dendritic polymer Polymers 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 238000011033 desalting Methods 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• 238000009792 diffusion process Methods 0.000 description 1
• 230000008034 disappearance Effects 0.000 description 1
• 230000005750 disease progression Effects 0.000 description 1
• 235000021186 dishes Nutrition 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 125000002228 disulfide group Chemical group 0.000 description 1
• 238000013104 docking experiment Methods 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 230000003828 downregulation Effects 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• 238000002651 drug therapy Methods 0.000 description 1
• 229920001971 elastomer Polymers 0.000 description 1
• 239000012149 elution buffer Substances 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 229940116977 epidermal growth factor Drugs 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 210000002980 germ line cell Anatomy 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 239000003966 growth inhibitor Substances 0.000 description 1
• 229940029575 guanosine Drugs 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 238000002169 hydrotherapy Methods 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 229960000598 infliximab Drugs 0.000 description 1
• 230000010365 information processing Effects 0.000 description 1
• 238000011081 inoculation Methods 0.000 description 1
• 239000002054 inoculum Substances 0.000 description 1
• 238000009434 installation Methods 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 230000009878 intermolecular interaction Effects 0.000 description 1
• 239000010410 layer Substances 0.000 description 1
• 238000007834 ligase chain reaction Methods 0.000 description 1
• 238000007854 ligation-mediated PCR Methods 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 239000007791 liquid phase Substances 0.000 description 1
• 238000007403 mPCR Methods 0.000 description 1
• 238000002824 mRNA display Methods 0.000 description 1
• 230000005291 magnetic effect Effects 0.000 description 1
• 210000000723 mammalian artificial chromosome Anatomy 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 230000007721 medicinal effect Effects 0.000 description 1
• 239000000693 micelle Substances 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 230000002438 mitochondrial effect Effects 0.000 description 1
• 238000000302 molecular modelling Methods 0.000 description 1
• SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 150000002482 oligosaccharides Chemical class 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 210000003463 organelle Anatomy 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 230000005298 paramagnetic effect Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 239000008194 pharmaceutical composition Substances 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• 235000021317 phosphate Nutrition 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 239000013600 plasmid vector Substances 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 239000004417 polycarbonate Substances 0.000 description 1
• 229920000515 polycarbonate Polymers 0.000 description 1
• 230000000379 polymerizing effect Effects 0.000 description 1
• 102000054765 polymorphisms of proteins Human genes 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 244000144977 poultry Species 0.000 description 1
• 235000013594 poultry meat Nutrition 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 230000003449 preventive effect Effects 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 238000004801 process automation Methods 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000009465 prokaryotic expression Effects 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 239000003223 protective agent Substances 0.000 description 1
• 230000004952 protein activity Effects 0.000 description 1
• 238000000159 protein binding assay Methods 0.000 description 1
• 239000008262 pumice Substances 0.000 description 1
• 238000003127 radioimmunoassay Methods 0.000 description 1
• 229940116176 remicade Drugs 0.000 description 1
• 230000008521 reorganization Effects 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000033458 reproduction Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 238000002702 ribosome display Methods 0.000 description 1
• 239000005060 rubber Substances 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 239000004576 sand Substances 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000010845 search algorithm Methods 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 230000037432 silent mutation Effects 0.000 description 1
• 239000010703 silicon Substances 0.000 description 1
• 229910052710 silicon Inorganic materials 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 239000002689 soil Substances 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 230000000392 somatic effect Effects 0.000 description 1
• 238000012306 spectroscopic technique Methods 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 230000003068 static effect Effects 0.000 description 1
• 238000003883 substance clean up Methods 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 210000004243 sweat Anatomy 0.000 description 1
• 210000001179 synovial fluid Anatomy 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 150000003536 tetrazoles Chemical class 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 229940113082 thymine Drugs 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 229960000575 trastuzumab Drugs 0.000 description 1
• 239000001226 triphosphate Substances 0.000 description 1
• 235000011178 triphosphate Nutrition 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 210000002700 urine Anatomy 0.000 description 1
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
• 229960005486 vaccine Drugs 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 239000011534 wash buffer Substances 0.000 description 1